June 20, 2014
Takeda Pharmaceutical launched on June 18 the hypertensive treatment Zacras Combination Tablets LD/HD, a fixed-dose combination of its angiotensin receptor blocker (ARB) Azilva (azilsartan) and the calcium channel blocker (CCB) amlodipine. The NHI price is set at 140.60 yen per...read more